Position in ADCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,372,481
-$22,752,519 QoQ
Shares Held
7,824,749
-5.7% QoQ
Ownership
6.13%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#4
of 113 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Prosight Management, LP holds $32,892,861 across 3 Drug Manufacturers - Specialty & Generic names. ADCT ranks #2 (25.5% of the industry book) .
All Filings in ADCT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,372,481 | 7,824,749 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,125,000 | 8,300,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,925,003 | 8,477,338 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $29,889,212 | 7,472,303 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,053,626 | 10,467,771 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,455,635 | 9,543,004 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,934,850 | 9,515,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,354,146 | 9,636,237 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,241,200 | 9,570,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,655,847 | 7,050,300 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,743,188 | 6,471,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,845,630 | 5,402,041 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,005,385 | 5,583,900 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,351,852 | 3,257,360 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,779,110 | 463,310 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,193,576 | 247,630 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||